Apps

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable...

Specific Health Guidance Service Utilizing the “Lav” Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!

TOKYO, May 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM," "we,” “us” or “our”), a holistic...

Hapbee Launches Redesigned Mobile App with AI-Powered Discovery Engine, Expanded Vibe Library and Real-Time In-App Support to Enhance Personalization, Usability, and User Engagement

Company Also Updates Status of Audited Financial StatementsVANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV:...

error: Content is protected !!